RA Capital Management
Private banking companyWikipedia
12
MENTIONS
7
EPISODES
7
PODCASTS
Search complete. 12 mentions across 7 episodes found for "RA Capital Management".
Oct 14, 2026
Ben McLeodHOST
An interesting approach on dealing with a disease like this.
Jeff MartinHOST
Yeah, they have a $30 million Series A that they raised recently, and it was sold by RA Capital.
Jeff MartinHOST
That was back in, oh my gosh, on my birthday again.
Jeff MartinHOST
May 27th, 2026, Therapeutics raises $30 million Series A by RA Capital to advance STM01.
Jeff MartinHOST
It's what I said when I came out of the womb.
Ben McLeodHOST
Right on.
Ben McLeodHOST
Cool.
Ben McLeodHOST
All right.
Rachel GlazerHOST
Speaking of your syndicate, uh, your Series A actually brought together some really interesting investors.
Rachel GlazerHOST
So you have traditional biotech investors like RA Capital, and then strategic investors like Regeneron Ventures and Merck Global Health Innovation Fund, technology-oriented investors like Playground and Pear.
Rachel GlazerHOST
So could you talk about how you decided on that mix, and what do you generally want investors to bring to the table other than capital?
Wyatt McDonnellGUEST
Yeah.
Wyatt McDonnellGUEST
Um, you know, having, you know, for example, Merck Global Health Innovation Fund or GHI helps us to align both our partnership and our equity incentives and to get strategic feedback in a setting that also doesn't tell us what we have to do with our pipeline.
Wyatt McDonnellGUEST
The same thing comes from the team at Regeneron Ventures, deep antibody biologic expertise, strategic perspective from one of the companies that has arguably defined the modern antibody industry.
Wyatt McDonnellGUEST
If you look to, you know, traditional biotech investors like RA Capital, having some of that, you know, clinical stage pattern recognition in your boardroom is great for all biotech companies that can, you know, access it.
Wyatt McDonnellGUEST
It's good to work with people who know what it takes to get a molecule from IND to approval, and that really is the next phase for us.
Max the BotHOST
Now biotech gives us a useful anchor against hype.
Max the BotHOST
On October eighth, Alex Wisner-Gross posted on X about a Conversations in Action episode with Peter Kolchinsky of RA Capital Management framed around AI curing every disease over the next ten years.
Max the BotHOST
That is the maximalist version of the biotech AI thesis.
Max the BotHOST
But today's web results also include a more grounded clinical signal.
Steve UsdinPANELIST
Another thing that I should mention is that one of the other defendants in the case is Serafa, and they're gonna have to make a separate case.
Steve UsdinPANELIST
I think that they're probably going to say, "Well, look," um, they're gonna point to the due diligence that RTW and RA Capital made, the, the lead investors in Serafa.
Steve UsdinPANELIST
I think they also might point out that this isn't the first time that Beam has alleged misappropriation of trade secrets.
Steve UsdinPANELIST
In twenty twenty-five, it sued Prime Medicine, asserting that Prime's AATD development program violated terms of a contract between the two companies.
Lindsay MartinHOST
Yeah, and, and when you think about in-licensing, I think that also accelerates the timeline and can, yeah, shift things a lot earlier.
Lindsay MartinHOST
Um, I, yeah, I talked with Emily Minkow from RA Capital as well about Solstice and, um, really interesting to see how they go about finding the asset, and then I know you also heavily participated in that round.
Lindsay MartinHOST
Um, do you think-
Julie GrantGUEST
And we're thrilled, and we're really grateful.
Jason MastGUEST
And...
Jason MastGUEST
You go to the 38th floor and there is RA Capital's Joshua Resnick talking about the firm's plans for China.
Jason MastGUEST
And he's sitting up there overlooking all of Shanghai.
Jason MastGUEST
And you have other VCs that are also opening up shops.
Alec LetchfieldGUEST
But we also have a thematic sleeve, which is both the structural kind of growth names, for example, in biotechnology.
Alec LetchfieldGUEST
We've got wonderful names like RA Capital, but also more optimistic kind of themes.
Alec LetchfieldGUEST
And that can be things like insurance, which we bought, I think, about two or three years back now through names like Nafila, which was a Bermudan kind of American-based group.
Alec LetchfieldGUEST
but also it can be a shipping company.